Shuttle Pharmaceuticals Holdings (SHPH) Total Non-Current Liabilities (2021 - 2026)

Shuttle Pharmaceuticals Holdings' Total Non-Current Liabilities history runs 6 years deep, the most recent figure standing at $8.4 million for Q1 2026.

• On a quarterly basis, Total Non-Current Liabilities rose 338.44% year-over-year to $8.4 million in Q1 2026; TTM through Mar 2026 was $8.4 million, a 338.44% increase from a year earlier, with the FY2025 full-year figure at $8.1 million, up 358.38% from the prior year.
• Total Non-Current Liabilities advanced to $8.4 million in Q1 2026 per SHPH's latest filing, from $8.1 million in the prior quarter.
• Across five years, Total Non-Current Liabilities topped out at $8.4 million in Q1 2026 and bottomed at $945765.0 in Q2 2023.
• The 5-year median for Total Non-Current Liabilities is $1.8 million (2024), against an average of $2.5 million.
• Across the five-year window, Total Non-Current Liabilities sank 49.83% in 2022 and soared 358.38% in 2025, its largest moves.
• Year by year, Total Non-Current Liabilities stood at $975676.0 in 2022, then surged by 51.84% to $1.5 million in 2023, then grew by 19.6% to $1.8 million in 2024, then surged by 358.38% to $8.1 million in 2025, then gained by 3.91% to $8.4 million in 2026.
• Per Business Quant, the three latest SHPH Total Non-Current Liabilities figures stand at $8.4 million (Q1 2026), $8.1 million (Q4 2025), and $1.7 million (Q3 2025).